CME and Cboe Drag Washington to Court Over Perpetual Futures Coming Onshore

Perpetual futures are officially welcome in America, and the old guard is furious. The CFTC cleared Bitcoin perpetuals in May 2026 — the first time the contracts could trade on a US-registered exchange — then followed with approval for single-stock equity perps on November 3, 2026. Four executives at incumbent exchanges and other market players told Reuters the products could inject serious new risk into the multitrillion-dollar US derivatives market.

The mechanics are what spook them. Standard futures carry an expiry date and force traders to settle or roll; perps never expire and never close, using a funding rate to stay pegged to the underlying asset. Offshore venues have handed out 50x to 100x leverage, where a 2% move against a position can erase the whole stake. Regulated US platforms would likely cap leverage near 6x.

Who trades them matters too. Perps skew heavily retail rather than the institutional desks that dominate regulated futures, and critics argue the combination of 24/7 trading, no expiration and a retail crowd sits badly with risk systems rebuilt after 2008 around products that have both lifespans and closing bells.

The push to onshore has been led by CFTC Chairman Michael S. Selig, and the prize is large: offshore crypto perp volume hit $61.7 trillion in 2025, up 29% year over year, almost all of it outside US oversight. In August 2026, President Trump discussed bringing platforms like Hyperliquid, a major decentralized perps venue, onshore. The argument from Washington is simple — Americans are trading this stuff anyway, so route the volume through regulated domestic venues.

Wall Street's answer came in court. CME Group sued the CFTC in June 2026 over the Bitcoin approval, arguing perps should be classified as swaps, not futures, since the label decides which rules apply and which venues can list them. A second front opened in early November 2026, when a group including Cboe and Citadel filed follow-on litigation targeting the equity perps decision directly.

If CME wins the swap argument, the regulatory footing under both CFTC approvals could give way. Trading volume shifting to regulated US venues would be a tailwind for firms like Kalshi and Robinhood, while offshore players including Hyperliquid face domestic competition for American users. Whether that $61.7 trillion actually crosses the border hinges on traders accepting lower leverage in return for regulatory cover.